Status:
WITHDRAWN
Effect of Dexmedetomidine on Microcirculation in Patients Undergoing Extracorporeal Shock Wave Lithotripsy
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Microcirculation
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
Dexmedetomidine administration for minor procedure, such as extracorporeal shock wave lithotripsy, provides good quality of sedation and analgesia. Dexmedetomidine is a highly selective α2-adrenergic ...
Eligibility Criteria
Inclusion
- Patient who is older than 18 years old and less than 75 years old
- Patient who receive extraproporeal shock wave lithotripsy with ASA class I or II
- Patient who has understood the inform consent and agree to participate this study
Exclusion
- Patient's hemodynamic status is unstable in spite of adequate management or presence of signs of shock
- Patient who has a past history of allergy to s dexmedetomidine
- Patient who has history of cardiovascular, renal or hepatic dysfunction
- Patient who has participated in any other investigational study of other drugs currently
- Female patient who is pregnant or considers breast feeding currently
- Patient who has suspected full stomach
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01179438
Start Date
August 1 2010
End Date
June 1 2011
Last Update
December 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital, anesthesiology department
Taipei, Taiwan, 100